Causal Relationship Between Circulating Omega‐3 Fatty Acid and Cerebral Small Vessel Disease: A Mendelian Randomization Study

Cerebral small vessel disease (CSVD) plays an important role in the onset of stroke and cognitive dysfunction. Its primary imaging manifestations encompass lacunar stroke (LS), white matter hyperintensity (WMH), white matter perivascular space (WMPVS), and cerebral microbleed (CMB). While omega-3 fatty acid (FA) has shown potential protective effects against vascular diseases, their causal role in CSVD remains unclear. This study aims to investigate the causal relationship between circulating Omega-3 FA levels and various CSVD phenotypes using Mendelian randomization (MR). Data on circulating omega-3 FA levels were derived from a large genome-wide association study (GWAS) summary dataset comprising 115,060 individuals. Data on CSVD phenotypes were obtained from several large GWAS datasets, including those on LS (6030 cases, 248,929 controls), WMH (<i>N</i> = 42,310), CMB (3556 cases, 22,306 controls), and WMPVS (9223 cases, 29,648 controls). Suitable genetic variants were extracted from GWAS summary data to serve as instrumental variables (IVs) for a two-sample MR analysis. The primary method used was inverse variance weighted (IVW), supplemented by the weighted median (WM) and MR-Egger method to assess causality. Multiple sensitivity analyses were used to assess the robustness of the results. Elevated circulating Omega-3 FA levels were found to significantly reduce the risk of CMB (IVW OR = 0.82, 95% CI: 0.69-0.96). However, no significant associations were observed with WMH, WMPVS, or LS. Sensitivity analyses confirmed the stability of these results, with no indications of horizontal pleiotropy or reverse causality. This study suggests that higher circulating omega-3 FA levels may be causally associated with a modest reduction in the risk of cerebral microbleeds. These findings highlight the potential of omega-3 FA as a modifiable factor for preventing CMB and encourage further research in diverse populations.

Authors

Institutions

Publication Details

Journal
Food Science & Nutrition
Published
2025-12-01
DOI
https://doi.org/10.1002/fsn3.71344
Primary Topic
Fatty Acid Research and Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causal Relationship Between Circulating Omega‐3 Fatty Acid and Cerebral Small Vessel Disease: A Mendelian Randomization Study

Meijun Liu, Y Zhang, Xiaofeng Lv, Jingtao Liang et al.
Food Science & Nutrition
Fatty Acid Research and Health
article

Causal Relationship Between Circulating Omega‐3 Fatty Acid and Cerebral Small Vessel Disease: A Mendelian Randomization Study

Meijun Liu, Y Zhang, Xiaofeng Lv, Jingtao Liang, Xinmin Deng, Rui Lai, Lingxue Gong
article en

Abstract

Cerebral small vessel disease (CSVD) plays an important role in the onset of stroke and cognitive dysfunction. Its primary imaging manifestations encompass lacunar stroke (LS), white matter hyperintensity (WMH), white matter perivascular space (WMPVS), and cerebral microbleed (CMB). While omega-3 fatty acid (FA) has shown potential protective effects against vascular diseases, their causal role in CSVD remains unclear. This study aims to investigate the causal relationship between circulating Omega-3 FA levels and various CSVD phenotypes using Mendelian randomization (MR). Data on circulating omega-3 FA levels were derived from a large genome-wide association study (GWAS) summary dataset comprising 115,060 individuals. Data on CSVD phenotypes were obtained from several large GWAS datasets, including those on LS (6030 cases, 248,929 controls), WMH (<i>N</i> = 42,310), CMB (3556 cases, 22,306 controls), and WMPVS (9223 cases, 29,648 controls). Suitable genetic variants were extracted from GWAS summary data to serve as instrumental variables (IVs) for a two-sample MR analysis. The primary method used was inverse variance weighted (IVW), supplemented by the weighted median (WM) and MR-Egger method to assess causality. Multiple sensitivity analyses were used to assess the robustness of the results. Elevated circulating Omega-3 FA levels were found to significantly reduce the risk of CMB (IVW OR = 0.82, 95% CI: 0.69-0.96). However, no significant associations were observed with WMH, WMPVS, or LS. Sensitivity analyses confirmed the stability of these results, with no indications of horizontal pleiotropy or reverse causality. This study suggests that higher circulating omega-3 FA levels may be causally associated with a modest reduction in the risk of cerebral microbleeds. These findings highlight the potential of omega-3 FA as a modifiable factor for preventing CMB and encourage further research in diverse populations.

Food Science & NutritionVol. 13(12)
Guiyang Medical University (CN), Chengdu University of Traditional Chinese Medicine (CN)
Natural Science Foundation of Sichuan Province, Medical Research Council
Openalex Percentile: Top 53%
Fatty Acid Research and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.